| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.71e-04 | 17 | 23 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.38e-04 | 27 | 23 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.67e-03 | 207 | 23 | 3 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.69e-03 | 208 | 23 | 3 | GO:0005342 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.95e-03 | 57 | 23 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.16e-03 | 60 | 23 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.53e-03 | 65 | 23 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.53e-03 | 65 | 23 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.35e-03 | 75 | 23 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 3.52e-03 | 77 | 23 | 2 | GO:0005230 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.46e-03 | 293 | 23 | 3 | GO:0008514 | |
| GeneOntologyBiologicalProcess | acid secretion | 3.41e-05 | 57 | 23 | 3 | GO:0046717 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 4.36e-05 | 180 | 23 | 4 | GO:0060078 | |
| GeneOntologyBiologicalProcess | reproductive behavior | 7.46e-05 | 74 | 23 | 3 | GO:0019098 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.43e-04 | 92 | 23 | 3 | GO:0051966 | |
| MousePheno | decreased circulating triglyceride level | 3.46e-05 | 275 | 20 | 5 | MP:0002644 | |
| MousePheno | decreased triglyceride level | 1.06e-04 | 348 | 20 | 5 | MP:0005318 | |
| Domain | EGF_3 | 9.50e-05 | 12 | 23 | 2 | PF12947 | |
| Domain | EGF_dom | 9.50e-05 | 12 | 23 | 2 | IPR024731 | |
| Domain | Iontro_rcpt | 2.19e-04 | 18 | 23 | 2 | IPR001320 | |
| Domain | Lig_chan | 2.19e-04 | 18 | 23 | 2 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 2.19e-04 | 18 | 23 | 2 | PF10613 | |
| Domain | PBPe | 2.19e-04 | 18 | 23 | 2 | SM00079 | |
| Domain | Iono_rcpt_met | 2.19e-04 | 18 | 23 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.19e-04 | 18 | 23 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 2.19e-04 | 18 | 23 | 2 | SM00918 | |
| Domain | ANF_receptor | 9.41e-04 | 37 | 23 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 9.41e-04 | 37 | 23 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 1.05e-03 | 39 | 23 | 2 | IPR028082 | |
| Domain | EGF_CA | 4.98e-03 | 86 | 23 | 2 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 6.29e-03 | 97 | 23 | 2 | IPR018097 | |
| Domain | EGF_CA | 6.54e-03 | 99 | 23 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.67e-03 | 100 | 23 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.47e-03 | 106 | 23 | 2 | IPR000152 | |
| Domain | EGF_CA | 9.79e-03 | 122 | 23 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.01e-02 | 124 | 23 | 2 | IPR001881 | |
| Domain | EGF | 1.04e-02 | 126 | 23 | 2 | PF00008 | |
| Domain | Growth_fac_rcpt_ | 1.56e-02 | 156 | 23 | 2 | IPR009030 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 3.72e-05 | 154 | 18 | 4 | M27832 | |
| Pathway | WP_CHOLESTEROL_METABOLISM | 9.87e-05 | 72 | 18 | 3 | M46457 | |
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 10446940 | ||
| Pubmed | 1.50e-05 | 9 | 23 | 2 | 9892651 | ||
| Pubmed | 2.29e-05 | 11 | 23 | 2 | 11792727 | ||
| Pubmed | Conserved and Divergent Features of Human and Mouse Kidney Organogenesis. | 5.66e-05 | 17 | 23 | 2 | 29449453 | |
| Pubmed | Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels. | 1.05e-04 | 23 | 23 | 2 | 29237738 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.14e-04 | 24 | 23 | 2 | 35746896 | |
| Pubmed | 1.56e-04 | 28 | 23 | 2 | 28847650 | ||
| Pubmed | Reevaluating human gene annotation: a second-generation analysis of chromosome 22. | 2.18e-04 | 33 | 23 | 2 | 12529303 | |
| Pubmed | 2.60e-04 | 36 | 23 | 2 | 33737325 | ||
| Pubmed | 3.21e-04 | 40 | 23 | 2 | 20308539 | ||
| Cytoband | 22q13.33 | 1.67e-04 | 38 | 23 | 2 | 22q13.33 | |
| Cytoband | 1p34.3 | 4.46e-04 | 62 | 23 | 2 | 1p34.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 9.46e-03 | 294 | 23 | 2 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.18e-02 | 330 | 23 | 2 | chr22q13 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-05 | 107 | 23 | 3 | fc07dd90f280191bd643398eac5c8273651d0925 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.07e-05 | 119 | 23 | 3 | e868453c02dcf0e07821886b81ca739887d43c67 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.31e-05 | 143 | 23 | 3 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.62e-05 | 154 | 23 | 3 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.15e-05 | 158 | 23 | 3 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.56e-05 | 161 | 23 | 3 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-05 | 169 | 23 | 3 | 2e15a9317da4017757d184f7cc91bd66b072ac51 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.72e-05 | 169 | 23 | 3 | d0c64ca31053dfc283a07d5ad1117ca7dc1777a7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.72e-05 | 169 | 23 | 3 | d79abfbeffd082a4fbffbc1051ffc474374874fa | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 9.03e-05 | 171 | 23 | 3 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | droplet-Kidney-nan-21m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 176 | 23 | 3 | 0475db3f860de1e216cbdeb886f7a75b9f4fc801 | |
| ToppCell | droplet-Kidney|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 180 | 23 | 3 | 7e5f497699876ac8e1ce780626c6f5a1f6f5f079 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 182 | 23 | 3 | 942c18a27b22fb33a5200d5717cad972f3ef0576 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 183 | 23 | 3 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 187 | 23 | 3 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 193 | 23 | 3 | 55f37fdba469bea9869a34c4d4f00cb1a3b7a73f | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 1.29e-04 | 193 | 23 | 3 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 196 | 23 | 3 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 197 | 23 | 3 | 9b038dac4d4d306aa40ec07d79374c4fe9c604a6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 198 | 23 | 3 | a9d72b17adfddb6ac1857c5f094280e86582693b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 198 | 23 | 3 | b933bd66f544822fcf1f2aa2d928c31500e2b3f4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 198 | 23 | 3 | 72733b6149b797ac11cc108bc80428b77fbbba78 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 198 | 23 | 3 | f23559ce6072e3c323f6791ff95269271b0f7ff1 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 199 | 23 | 3 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-04 | 199 | 23 | 3 | 4e0b73d88b1345ec63a9e5629762341e75beb47f | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.41e-04 | 199 | 23 | 3 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | COVID_non-vent-Myeloid|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.44e-04 | 200 | 23 | 3 | a40768e8e58c86b8e20bc188b9274ebe412fc765 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 05bcde6ce8f1354ef65e4eb9cbd963a92108081c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 1a04331862079092bc04b1010aa9228c0fa3d8c5 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | fb56d430957e73fba17db7bc0127ecf3577e0867 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.44e-04 | 200 | 23 | 3 | 465ed50e0b92bb8c27ffe56d816f063a45b52be9 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.44e-04 | 200 | 23 | 3 | 4243a9d32f3a11141284d0d944cb81194b532876 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.11e-03 | 96 | 23 | 2 | 78f19fee755061b4144b1beebb60f4e8bc4dbf0d | |
| ToppCell | Frontal_cortex-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Gja1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.13e-03 | 97 | 23 | 2 | 031bc124739541b0b2591e1b6ef41f12adfd5c18 | |
| ToppCell | Frontal_cortex-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Gja1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.13e-03 | 97 | 23 | 2 | 0cd19f619f10a35d3107518aa83c0eda0572930a | |
| ToppCell | Frontal_cortex-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Gja1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.13e-03 | 97 | 23 | 2 | 33330ac2de9e49d78b478f175068999235c9af25 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.42e-03 | 109 | 23 | 2 | 5d194bf95eb777fb4d01bbe5b1639f17ea1bc11a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-03 | 113 | 23 | 2 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-03 | 115 | 23 | 2 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-03 | 121 | 23 | 2 | 056d0f0f7a4d1b2d38b83647bbe4468b7c959ce6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.78e-03 | 122 | 23 | 2 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.81e-03 | 123 | 23 | 2 | ad22e41661e7d26d40cd133702003281ccfbedbf | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-03 | 124 | 23 | 2 | a7b7d8b14d1218194da8fcf69b4780b6e9469332 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.86e-03 | 125 | 23 | 2 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-03 | 126 | 23 | 2 | 28fbe63f7bc628b32d8e86bf9e80657e776dd1cc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-03 | 126 | 23 | 2 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-03 | 129 | 23 | 2 | 6abdba987c8528f7cb90b32dc01796e02c7352c9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.98e-03 | 129 | 23 | 2 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.98e-03 | 129 | 23 | 2 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.04e-03 | 131 | 23 | 2 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.08e-03 | 132 | 23 | 2 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.11e-03 | 133 | 23 | 2 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-03 | 134 | 23 | 2 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.17e-03 | 135 | 23 | 2 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.20e-03 | 136 | 23 | 2 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-03 | 137 | 23 | 2 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.33e-03 | 140 | 23 | 2 | eb1d22f5f5dbf60b6485464baec4be9b3060f65c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.36e-03 | 141 | 23 | 2 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-03 | 142 | 23 | 2 | 5690eee2ce1ecd02e34eac4193578bd13c4228b9 | |
| ToppCell | severe_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 2.43e-03 | 143 | 23 | 2 | 28b0e168126a9fe60541dc12bfab385b7a0a2342 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.46e-03 | 144 | 23 | 2 | 76c0e551864c4faab7528c4ecf1a40d7ea60569f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.46e-03 | 144 | 23 | 2 | 0322fef818a963be00535d5f141f028d43de5c6a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.46e-03 | 144 | 23 | 2 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.50e-03 | 145 | 23 | 2 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.56e-03 | 147 | 23 | 2 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.60e-03 | 148 | 23 | 2 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.60e-03 | 148 | 23 | 2 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-03 | 148 | 23 | 2 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-03 | 149 | 23 | 2 | 23a1b95c12f2e3708dc003e13fab423e89821f11 | |
| ToppCell | facs-Skin-nan-18m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-03 | 149 | 23 | 2 | bb18a18b891af85849b9658d774053f839c9a8e1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.63e-03 | 149 | 23 | 2 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-03 | 149 | 23 | 2 | c53a3226adc8fd0eaaa842b6a96442287580cbe0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.63e-03 | 149 | 23 | 2 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-03 | 151 | 23 | 2 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-03 | 153 | 23 | 2 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.77e-03 | 153 | 23 | 2 | 14753baa9980f75206fefc3c8b43685fd4178a43 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.77e-03 | 153 | 23 | 2 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.81e-03 | 154 | 23 | 2 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-03 | 155 | 23 | 2 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-03 | 155 | 23 | 2 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-03 | 156 | 23 | 2 | d34f386985dd17293b1e320d732ab11b46be76ce | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.92e-03 | 157 | 23 | 2 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | 367C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-03 | 157 | 23 | 2 | f511871e1a004c6e9af08ee325ab1bfc41807487 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.95e-03 | 158 | 23 | 2 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-03 | 160 | 23 | 2 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l1-4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.03e-03 | 160 | 23 | 2 | 6329b0f02f9509086e563c2ed762a8ec693883b5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-03 | 160 | 23 | 2 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-03 | 160 | 23 | 2 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.03e-03 | 160 | 23 | 2 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-03 | 160 | 23 | 2 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.06e-03 | 161 | 23 | 2 | bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.06e-03 | 161 | 23 | 2 | aee74a2e7a8acd2950341963f1c04b59c7862183 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.06e-03 | 161 | 23 | 2 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-1|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.06e-03 | 161 | 23 | 2 | 9e03aa7c50b4e8cf1f726a524b5b03af886535b1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-03 | 162 | 23 | 2 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 3.14e-03 | 163 | 23 | 2 | 7d7f18e5c99be125e95bc180823430291b770d05 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.14e-03 | 163 | 23 | 2 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-03 | 164 | 23 | 2 | 4a834a7908d8aa643a2096c52430dad795898474 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-03 | 164 | 23 | 2 | ed7e0c8ccad7d19b9cc72d70391936ff5e698f28 | |
| Computational | Genes in the cancer module 13. | 3.40e-04 | 15 | 20 | 2 | MODULE_14 | |
| Computational | Genes in the cancer module 516. | 3.89e-04 | 16 | 20 | 2 | MODULE_516 | |
| Computational | Genes in the cancer module 178. | 4.40e-04 | 17 | 20 | 2 | MODULE_178 | |
| Computational | Genes in the cancer module 165. | 4.44e-04 | 82 | 20 | 3 | MODULE_165 | |
| Computational | Genes in the cancer module 444. | 4.94e-04 | 18 | 20 | 2 | MODULE_444 | |
| Computational | Angiogenesis. | 6.76e-04 | 21 | 20 | 2 | MODULE_362 | |
| Computational | Neighborhood of HMGA2 | 1.45e-03 | 123 | 20 | 3 | GCM_HMGA2 | |
| Drug | CX516 | 1.37e-06 | 22 | 23 | 3 | CID000148184 | |
| Drug | 6,7-dinitroquinoxaline | 4.82e-06 | 33 | 23 | 3 | CID002724608 | |
| Drug | perzinfotel | 2.72e-05 | 8 | 23 | 2 | CID006918236 | |
| Drug | Celecoxib | 3.15e-05 | 376 | 23 | 5 | ctd:D000068579 | |
| Drug | L-Glutamic Acid | 4.32e-05 | 68 | 23 | 3 | DB00142 | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A | 4.49e-05 | 200 | 23 | 4 | 3056_UP | |
| Drug | felbamate | 4.72e-05 | 70 | 23 | 3 | CID000003331 | |
| Drug | T2755 | 4.92e-05 | 71 | 23 | 3 | CID000005514 | |
| Drug | AC1L1B1W | 8.13e-05 | 84 | 23 | 3 | CID000001248 | |
| Drug | remacemide | 8.82e-05 | 14 | 23 | 2 | CID000060510 | |
| Drug | hexachlorophene | 9.99e-05 | 90 | 23 | 3 | CID000003598 | |
| Drug | ACEA-1011 | 1.02e-04 | 15 | 23 | 2 | CID000127872 | |
| Drug | argiopine | 1.16e-04 | 16 | 23 | 2 | CID000122294 | |
| Drug | 3HPG | 1.32e-04 | 17 | 23 | 2 | CID000001217 | |
| Drug | EN-1530 | 1.60e-04 | 278 | 23 | 4 | CID000004425 | |
| Drug | IDRA 21 | 1.83e-04 | 20 | 23 | 2 | CID000003688 | |
| Drug | NS 102 | 2.23e-04 | 22 | 23 | 2 | CID005282252 | |
| Drug | kynurenic acid | 2.46e-04 | 122 | 23 | 3 | CID000003845 | |
| Drug | muscimol | 2.90e-04 | 129 | 23 | 3 | CID000004266 | |
| Drug | aniracetam | 2.96e-04 | 130 | 23 | 3 | CID000002196 | |
| Drug | 2-chloropropionate | 3.37e-04 | 27 | 23 | 2 | CID000011734 | |
| Drug | AC1NUW3V | 3.90e-04 | 29 | 23 | 2 | CID005462126 | |
| Drug | Pb-D | 3.92e-04 | 143 | 23 | 3 | CID000070065 | |
| Drug | LY293558 | 4.17e-04 | 30 | 23 | 2 | CID000127894 | |
| Drug | AC1L32TU | 4.17e-04 | 30 | 23 | 2 | CID000107831 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 4.17e-04 | 30 | 23 | 2 | CID000001226 | |
| Drug | 4-methylglutamic acid | 4.46e-04 | 31 | 23 | 2 | CID000005365 | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.68e-04 | 152 | 23 | 3 | 6807_UP | |
| Drug | AC1O5D5R | 5.06e-04 | 33 | 23 | 2 | CID006482240 | |
| Drug | kainite | 5.69e-04 | 35 | 23 | 2 | CID000164810 | |
| Drug | glutamic acid diethyl ester | 6.02e-04 | 36 | 23 | 2 | CID000073960 | |
| Drug | R,S)-AMPA | 6.02e-04 | 36 | 23 | 2 | CID000001221 | |
| Drug | haloperidol | 6.03e-04 | 394 | 23 | 4 | CID000003559 | |
| Drug | gamma-Glu-Gly | 6.36e-04 | 37 | 23 | 2 | CID000100099 | |
| Drug | gabapentin | 6.38e-04 | 169 | 23 | 3 | CID000003446 | |
| Drug | GAMs | 6.71e-04 | 38 | 23 | 2 | CID000002935 | |
| Drug | L-BMAA | 6.71e-04 | 38 | 23 | 2 | CID000028558 | |
| Drug | CGS 19755 | 6.71e-04 | 38 | 23 | 2 | CID000068736 | |
| Drug | DETC-MeSO | 7.07e-04 | 39 | 23 | 2 | CID003035711 | |
| Drug | HA-966 | 7.07e-04 | 39 | 23 | 2 | CID000001232 | |
| Drug | 7-OH-DPAT | 7.07e-04 | 39 | 23 | 2 | CID000001219 | |
| Drug | strychnine HCl | 7.78e-04 | 181 | 23 | 3 | CID000005304 | |
| Drug | picrotoxin | 7.78e-04 | 181 | 23 | 3 | CID000031304 | |
| Drug | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 8.16e-04 | 184 | 23 | 3 | ctd:C576882 | |
| Drug | AC1Q6X9N | 8.20e-04 | 42 | 23 | 2 | CID000072205 | |
| Drug | LY341495 | 8.60e-04 | 43 | 23 | 2 | CID006324636 | |
| Drug | Joro spider toxin | 8.60e-04 | 43 | 23 | 2 | CID000119582 | |
| Drug | diazepam | 8.82e-04 | 189 | 23 | 3 | CID000003016 | |
| Drug | saclofen | 9.00e-04 | 44 | 23 | 2 | CID000122150 | |
| Drug | 7-chlorokynurenic acid | 9.41e-04 | 45 | 23 | 2 | CID000001884 | |
| Drug | philanthotoxin | 9.41e-04 | 45 | 23 | 2 | CID000115201 | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 1665_DN | |
| Drug | retinoic acid; Down 200; 1uM; HL60; HG-U133A | 9.80e-04 | 196 | 23 | 3 | 390_DN | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5202_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 2088_UP | |
| Drug | Moxonidine [75438-57-2]; Up 200; 16.6uM; HL60; HT_HG-U133A | 1.02e-03 | 199 | 23 | 3 | 2923_UP | |
| Drug | NaCN | 1.03e-03 | 47 | 23 | 2 | CID000008929 | |
| Drug | flurothyl | 1.03e-03 | 47 | 23 | 2 | CID000009528 | |
| Drug | sodium 4-phenylbutyrate; Down 200; 100uM; HL60; HG-U133A | 1.04e-03 | 200 | 23 | 3 | 363_DN | |
| Drug | arachidonic acid sodium salt; Up 200; 10uM; MCF7; HG-U133A | 1.04e-03 | 200 | 23 | 3 | 604_UP | |
| Drug | Isotretinoin | 1.04e-03 | 799 | 23 | 5 | ctd:D015474 | |
| Drug | felbamate | 1.07e-03 | 48 | 23 | 2 | ctd:C047360 | |
| Drug | One-time | 1.07e-03 | 48 | 23 | 2 | CID000040813 | |
| Disease | kidney disease (implicated_via_orthology) | 4.33e-06 | 41 | 23 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | Parkinsonism (biomarker_via_orthology) | 3.21e-04 | 34 | 23 | 2 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | Schizophrenia | 5.10e-04 | 883 | 23 | 5 | C0036341 | |
| Disease | response to opioid | 1.03e-03 | 61 | 23 | 2 | EFO_0008541 | |
| Disease | platelet component distribution width | 2.56e-03 | 755 | 23 | 4 | EFO_0007984 | |
| Disease | Psychotic Disorders | 2.80e-03 | 101 | 23 | 2 | C0033975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRFFGNTWAEMYRNR | 221 | O95154 | |
| GVWDMRGKQFYNGIE | 431 | Q9UL18 | |
| AQRWGIRKGIVMGFF | 311 | O95342 | |
| DFQRGWKEYKMGFGN | 336 | Q15389 | |
| GRNEAWRYMGGFAKS | 46 | O43676 | |
| GQVMTGYYRWLQRAG | 361 | Q99742 | |
| FMWYRSKERGQRGFS | 176 | P80404 | |
| WFRGFNMRTGERGVF | 641 | Q13387 | |
| YMGEWKNDKRNGFGV | 281 | Q9HDC5 | |
| AAMSWQDGRVYFFKG | 431 | Q99542 | |
| RSLYGGFVEWQMGEQ | 161 | P53602 | |
| GRREKGFQMQWFVYG | 1376 | O60494 | |
| QVRNMGFGDGFWRQR | 591 | Q8TE85 | |
| AFFMRRTFGGNKLYW | 206 | O15228 | |
| KRLGAGQFGEVWMGY | 251 | P07948 | |
| WRFGGRFMNFIKEAQ | 356 | Q13003 | |
| KADFRGQWVLMYFGF | 116 | O43819 | |
| MFTWGRADYGQLGRK | 286 | Q9UGK8 | |
| WGNYGRMERKQFMGV | 201 | Q9H426 | |
| MWFRGAGAGRELIYN | 66 | O00241 | |
| GWYRFVGQGGARMAE | 201 | P07911 | |
| LKRQGYGEGFRWMAQ | 181 | Q9Y6B6 | |
| RVRGVWNGMIGEVYY | 486 | Q14957 |